RT @HenryMuney: Neuro-oncologist Linda Liau, MD, PhD, MBA led brain tumor vaccine trials with success and clinically meaningful benefit. Li…
Neuro-oncologist Linda Liau, MD, PhD, MBA led brain tumor vaccine trials with success and clinically meaningful benefit. Linda Liau should be @TIME's person of the year! 1. https://t.co/pfRDJT4azX 2. https://t.co/PmBaKXMdBr 3. https://t.co/hYrTDQcQK6 4.
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @alphavestcap: https://t.co/ESf2Mhs2Rg $nwbo @alphavestcap
RT @jman4956: @rickberke @statnews Here’s some breaking news. $NWBO #LindaLiau https://t.co/m7U1ToXYd1
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
@rickberke @statnews Here’s some breaking news. $NWBO #LindaLiau https://t.co/m7U1ToXYd1
RT @alphavestcap: https://t.co/ESf2Mhs2Rg $nwbo @alphavestcap
“The mOS for patients with nGBM assigned to the DCVax-L cohort at enrollment was 19.3 months from the time of randomization (22.4 months from surgery) compared with 16.5 months from randomization for the 1366-patient ECP (log-rank HR, 0.80; 95% CI, 0.00-0.
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
https://t.co/ESf2Mhs2Rg $nwbo @alphavestcap
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @COILPOD: This morning’s presentation. $NWBO
RT @ElvirPons: Congratulations Dr. Liau!!
RT @bjoeedwards: $NWBO #murcidencel
RT @rickcav: $NWBO
RT @AlMusella: https://t.co/sowFiBVVhA The DCVAX peer reviewed journal article is now available online! #DCVAX #SNO2022 #GBM
RT @ElvirPons: Congratulations Dr. Liau!!
$NWBO #SNO2022
RT @roelverhaak: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Ne…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
$NWBO #murcidencel
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
Congratulations Dr. Liau!!
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @rickcav: $NWBO
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @FlemmingBruce: $NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
RT @joostverhoeff: Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Pat…
$NWBO #LindaLiau Nobel Prize lady in her shining moment ❤️
$NWBO
RT @EveryTrade: $NWBO https://t.co/CZiCWtBvk1
This morning’s presentation. $NWBO
Congrats Linda Liau and Team! #SNO2022 $nwbo
$NWBO https://t.co/CZiCWtBvk1
Promising Overall Survival results from Phase 3 trial of Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma presented by prof Linda Liau at #sno2022 @NeuroOnc https://t.co/VfEl4MAtYC https
Minor improvement in overall survival and implicated as an approach to increase T-cell infiltration into the tumor, critical for better immunotherapy responses in glioma
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma https://t.co/Nx0qd3Iplc
1/2 גליובלסטומה היא סרטן מוח קטלני ביותר, עם שיעור הישנות של כמעט 100% ושיעור הישרדות נמוך מאוד. פירסום פורץ דרך ב-JAMA מראה כי בניסוי שלב III בו טיפול בחולים בחיסון חדש, DCVax®-L, שפותח על ידי חברת Northwest Biotherapeutics, https://t.co/EHELVDCkTb http
Figured I should update my pinned tweet from May 10th. $NWBO #LindaLiau #DCVax #Murcidencel #GBM #Cancer #CancerResearch #AllSolidTumors Source: https://t.co/iPUOKBP55j https://t.co/GahppEyhdh
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial | Neuro-oncology | JAMA Oncology h
RT @sentimentstock: To hear Linda Liau speak with Dr. Jack West about the @JAMAOnc article: click this link, scroll to the article (4th d…
RT @rkawong66: https://t.co/eewHx0aC9o. $NWBO
RT @rkawong66: https://t.co/eewHx0aC9o. $NWBO
RT @sentimentstock: To hear Linda Liau speak with Dr. Jack West about the @JAMAOnc article: click this link, scroll to the article (4th d…
RT @kevinjsears: Great news for people with solid tumor cancers and those who hold stock in $NWBO @BBCBreaking @ABC @NBCNews @FoxNews @CNBC…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @kevinjsears: Great news for people with solid tumor cancers and those who hold stock in $NWBO @BBCBreaking @ABC @NBCNews @FoxNews @CNBC…
RT @HassanClan: #NWBO #DCVax #murcidencel @WTOP Right here in Bethesda, MD "[DCVax]... ranks [as] one of the most commercially and medicall…
@wxpete22 Can you a link to the @AlMusella's post itself? You have a screen capture here, but I cannot find the post on his feed. I find something very similar, but the language is somewhat different. So I am confused. What happened to the one you sna